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Despite major advances in pain management, cancer pain is managed poorly in 80% of
the patients with cancer. Due to deleterious side effects of pharmacology therapy in these
people, there is an urgent need for clinical trials of non-pharmacological interventions.
To examine the effect of therapeutic touch (TT) on the pain and fatigue of the cancer patients
undergoing chemotherapy, a randomized and three-groups experimental study—experimental
(TT), placebo (placebo TT), and control (usual care)—was carried out. Ninety patients
undergoing chemotherapy, exhibiting pain and fatigue of cancer, were randomized into one
of the three groups in the Cancer Center of Imam Khomeini Hospital in Tehran, Iran. Pain
and fatigue were measured and recorded by participants before and after the intervention for
5 days (once a day). The intervention consisted of 30min TT given once a day for 5 days
between 10:00a.m. and 10:30a.m. The Visual Analogue Scale (VAS) of pain and the Rhoten
Fatigue Scale (RFS) were completed for 5 days before and after the intervention by the
subjects. The TT (significant) was more effective in decreasing pain and fatigue of the
cancer patients undergoing chemotherapy than the usual care group, while the placebo group
indicated a decreasing trend in pain and fatigue scores compared with the usual care group.
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Introduction
over the last several years, hospitals have developed
comfort and pain management programs that support
minimizing pain and maximizing comfort for their
patients (1). Despite the major advances in pain manage-
ment, cancer pain is managed poorly in 80% of the
patients with cancer (2). Early studies on under treatment
cancer pain were focused on identification of the patients
(3), providers (4) and system barriers (5) to optimize
cancer pain management. There are two methods for
pain relieving in cancer patients: pharmacological and
non-pharmacological methods. Cancer patients have
misconceptions about tolerance, physical dependence
and psychological addiction (3). The outpatients with
cancer, with and without cancer pain, achieved an
average score of only 60% on the Pain Experience
Scale. In addition, another study results indicated that
the patients are given too much pain medicine (6).
Fatigue is the most frequently reported symptom of
cancer patients (7). Moreover, it is often reported that
this symptom is the most distressing parameter that
causes the greatest amount of interference with the
patient’s daily life (8). This symptom is also very
common among the patients with advanced diseases
who are receiving palliative treatment (9). In addition,
many cancer survivors report continued fatigue that
adversely impacts their quality of life (10). Most patients
with severe cancer pain may develop others associated
symptoms, commonly induced by opioids per se. Intensity
of the pain has been found to be associated with a low
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properly cited.level of function and higher intensity of symptoms. Pain
control may indirectly improve some symptoms and
other measures such as nausea and vomiting, well-being,
mood and appetite. Fatigue and loss of appetite are
correlated with pain intensity (11).
Therefore, to control pain and to decrease fatigue in the
patients undergoing chemotherapy, it is essential to
rigorously examine non-pharmacological interventions
that are less likely to result in deleterious side effects
that can elicit a relaxation response and can maintain
quality of life. One such non-pharmacological interven-
tion is therapeutic touch (TT).
Therapeutic Touch
TT was first described by Dora Kunz and researched by
Dolores Krieger, co-founder of TT in 1973. TT is based
on the assumption that the physical body is surrounded
by an aura (energy not visible to normal vision) and is
penetrated and kept alive by a universal energy called
prana (a Sanskrit word meaning vital force) that flows
through the body and is transformed by chakras or
non-physical vortices. Energy imbalance supposedly
results in illness, which can be intuitively assessed in a
form of psychic diagnosis, and then treated hands-on
(12). This view can be supported by the nursing theory
of Martha Rogers (1970, 1990) based entirely on a
field world view.
Rogers (1983) postulates that the human and environ-
mental fields are identified by wave patterns, and that
change is propagated by waves. Nursing interventions
such as TT are directed towards promoting the rhythmic
flow of energy waves that order and re-order the human
field. Symptoms are viewed as energy blockages, conges-
tion, dysrhythmias, or areas of imbalance in the field.
As dysrhythmias are corrected by TT, the whole field
becomes balanced. According to Rogers (1970, 1990),
human being is a complex energy field. Our present
technology does not allow the measurement of the
human energy field, but to a trained sense, primarily
touch, the human energy field can be perceived and
assessed. One is able to develop this sensitivity through
a process called ‘centering’, the attainment of a mental
state in which the practitioner quiets the mind, detaches
from inward and outward distractions, and focuses full
attention and intention on helping the patient (13).
Krieger (14) reviewed the most reliable clinical effects
of TT and concluded that: ‘Ranking highest in
reliability...is the very rapid relaxation response in the
healee’. This can be observed 2–4min after the start of
TT interaction. According to Krieger (14), the second
most reliable clinical effect of TT is ‘the amelioration or
eradication of pain’ (14).
Unlike Krieger, Meehan (15) has reported that TT is
not statistically significant in pain reduction, and
similarly concluded TT does not significantly decrease
postoperative pain during the first hour following the
intervention (15).
Winstead-Fry and Kijek (16) have reviewed 13 out
of the 18 published experimental studies on TT (Krieger/
Kunz method), revealing inconsistent results for several
reasons: small sample sizes; reliance on a single anxiety
measure (State-Trait Anxiety Inventory); the use of
healthy instead of ill participants; lack of consistent
operational definitions; short treatment time (<5min),
and single treatments with no follow-up measures over
the time (16). Few of these researches have been
tested using a placebo-controlled experimental design
(Class I evidence). A more complete summary has been
published by Doody et al. (17).
The present research attempted to study the effect of
TT on pain and fatigue in the cancer patients undergoing
chemotherapy by adequate sample size and placebo
group. Our hypothesis was that TT would decrease the
intensity of pain and fatigue in the patients under
chemotherapy.
Methods
Ninety randomly assigned participants were allocated to
one of the three groups (experimental, placebo and
control) using a randomized clinical trial (RCT), and a
three-group experimental pre-test/post-test design.
The experimental group received TT, the placebo group
received a mimic treatment that resembled TT to the
naive observer, and the control group received routine
care. The dependent variables were pain and fatigue,
measured by the patients undergoing chemotherapy.
TT intervention administered once daily for 5 days.
During the study, pain and fatigue were recorded before
and after the interventions daily for 5 days by self-report.
Sample and Setting
A convenience sample of cancer persons under
chemotherapy and suffering from pain and fatigue,
were selected from three special care units (with 14, 16
and 18 beds) when the patients were hospitalized
for receiving the chemotherapy drugs. The patients
themselves determined and recorded the intensity of
pain and fatigue within 5 days.
Criteria for participation in this study included the
residents who: (1) had a diagnosis of cancer; (2) had a
normal level of consciousness (Glassco Coma Scale,
GCS=15); (3) aged 15–65 years, and (4) had resided
in the unit for at least 5 days. The excluded residents
were those who had any diseases leading to experience of
pain (such as arthritis rheumatoid and osteo-sarcoma).
Since the practitioner was female, therefore, to observe
the cultural believes of the Moslems, all the subjects
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was determined as 90 participants (30 persons for
each group) according to the Nomogram’s Altman
(18) (clinical difference=2, standard error=3 and
power (1B)=0.90). After obtaining consent, all the
participants were enrolled into the study. The partici-
pants were randomly allocated in three study groups.
The study field was a referral center to which the cancer
patients were referred for treatment. Forty cancer
patients were confined to bed and intake of chemother-
apy drugs; therefore, they were discharged after 5 days.
Before the intervention, 90 cards numbered (1–90) were
provided and three pockets were randomly selected
for the study groups (A=control, B=placebo and
C=experimental). The numbered cards were selected
randomly and allocated in three pockets, respectively.
At the time when the patients referred to the center,
they were taken a number, respectively and, then,
allocated in their groups according to the numbers
in the pockets. The processes of selection and interven-
tion were continued for 3 months.
Measures
The Visual Analogue Scale (VAS) of pain and the
Rhoten Fatigue Scale (RFS) were used to measure pain
and fatigue of the patients.
VAS
The VAS is a 10cm line labeled ‘no pain’ at one end and
‘the pain is as much as I can bear’ at the other. Here, the
patients were given an explanation of the line and asked
to mark a point upon it which corresponded to their pain.
RFS
This scale developed by Rhoten in 1979, has 11-point
self-rating graphic VAS with verbal anchors on each end.
‘No fatigue’ at one end and ‘the fatigue is as much as I
can bear’ at the other. The clinical utility of the scale is
very easy to use.
Procedure
Following the approval by the Ethical Committee at the
Cancer Research Center of Imam Khomeini Hospital
(Tehran, Iran) and explanation of the study to the
participants, consent and demographic data were
obtained. The researcher was introduced to the patients.
The researcher who performed TT had received about
5 months of training by the specialist of TT. Pre-
intervention data collection was conducted over a 5-day
period before each intervention, to gather baseline data
using VAS questionnaire of pain and fatigue, filled by the
subjects (self-report) every day before (pre-test) and after
(post-test) the intervention.
TT in the Experimental Group
TT was delivered for 5 days (once a day at the same
time each day: between 10:00a.m. and 10:30a.m.).
The intervention was conducted in the privacy of the
participant’s room. The participants were guided or
gently led to their room prior to the beginning of the
intervention. They were laid on their backs on their
hospital beds for the treatment. Prior to the first
treatment, they were instructed to relax as fully as
possible and a brief explanation of TT procedures was
given. The intervention consisted of centering, assessment,
TT administration (directing human energies, modulating
human energies, changing patterns in human energy
field), reassessment of the patient’s energy field and
additional treatments as needed.
The intervention lasted for 30min. Since, there was no
previous research on which to base the length of
intervention, the length of intervention was determined
after expert consultation with the specialist of TT and
the clinical expertise with cancer patients and considering
the participant’s psychological and physical status and
restlessness.
Placebo Intervention
The placebo intervention consisted of mimic TT. Mimic
treatments were provided to the placebo group by the
practitioner. She performed the same movements used by
the practitioner during the TT process (the duration was
the same as the experimental group). However, instead of
centering and holding the intent to help the subject, as
the practitioner did in the TT intervention, here, she
simply began the treatment and counted back from 100
by serial sevens during the whole treatment. Mimic
treatments were given in the patients’ rooms. As in the
TT treatment, the patients laid on their back on the
hospital beds for the treatment. Prior to the first
treatment, they were instructed to relax as fully as
possible and a brief explanation of what would be done
during the mimic treatment was given.
Control Group
For the subjects in the control group, the practitioner did
not do any intervention except routine interventions in
the ward. The practitioner thanked the participants at the
completion of each intervention. Post-intervention data
collection was conducted in the same manner for 5 days
immediately after each intervention.
Validity and reliability of measures for the dependent
variables: pain and fatigue. Melzack (1975) has developed
the VAS and found the correlation consistently 0.80 for
pre-test and 0.85 for post-test measures. Winstead-Fry
(19) has shown that the scale is correlated with the Lee
Fatigue Scale (r=0.80) as well as the Profile of Mood
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20 of completed VAS and RFS questionnaires in the first
day of pre-test were bisected using the split-half reliability
technique and Pearson product moment correlation
coefficients were calculated to ascertain reliability.
The Pearson correlations for VAS and RFS were
r=0.82 and r=0.75, respectively. We did not use
test–retest technique because patients’ pain and fatigue
could vary in two different times.
Results
The sample consisted of 90 subjects divided into the
three groups of experimental, placebo and control groups
(30 patients in each group). The subjects were evenly
distributed in the three groups according to the type and
stage of cancer, narcotic analgesic use, numbers of
chemotherapy period and interval between the two
chemotherapy periods. Table 1 presents the demographic
characteristics and some confounding variables for
each group.
Efficacy: Pain Scores
Pain scores of the experimental group were reduced
compared to placebo and control groups’ pain scores
significantly. Since, the scales were administered several
times over the 5-day period (10 times to be precise), the
repeated measured ANOVA was used for the pain and
fatigue scores. The repeated measured ANOVA
(the means of difference between the VAS pain scores
before and after intervention) showed that there are
significant differences between three groups within the 5
days of intervention (F=2.01, df=8, P=0.04, n=90)
(Figure 1).
The Tukey HSD test was conducted to locate the
differences. The Tukey test of the means of difference
between the VAS pain scores before and after
the intervention showed that there was a significant
difference between the experimental and placebo groups
in the first (P<0.001), second (P<0.0001), third
(P<0.04), fourth (P<0.0001) and fifth days
(P<0.006) and between the experimental and control
groups in the first (P<0.001), second (P<0.0001), third
(P<0.001), fourth (P<0.0001) and fifth days
(P<0.0001). There was no significant difference between
the placebo and control groups in the first day
(P<0.14), but the differences between the placebo and
control groups in the second (P<0.0001), third
(P<0.005), fourth (P<0.008) and fifth days
(P<0.001) were statistically significant. Figure 1 shows
these values for 5 days.
Efficacy: Fatigue Scores
Fatigue scores of the experimental group were
reduced compared to placebo and control groups’
Table 1. Resident demographic characteristics for each group
Variable
(group n=30)












No literacy 4 (13.3%) 10 (33.3%) 8 (26.7%) 
2
Primary 15 (50%) 16 (53.3%) 10 (33.3%) P=0.21
Diploma
and High
11 (36.7%) 4 (33%) 12 (40%)
Have career in home
Yes 24 (80%) 21 (70%) 20 (66.7%) 
2
No 6 (20%) 9 (30%) 10 (33%) P=0.25
Social support resources
Yes 11 (36.7%) 10 (33.3%) 9 (30%) 
2
No 19 (63.3%) 20 (66.7%) 21 (70%) P=0.34
Surgery treatment
Yes 22 (73.3%) 21 (70%) 25 (83.3%) 
2
No 8 (26.7%) 9 (30%) 5 (16.7%) P=0.45
Chemotherapy sessions ANOVA
Mean (SD) 17.5 (15.15) 16.7 (12.96) 21.8 (24.6) P=0.51
Stage of cancer (TNM criteria)
II 8 (26.7%) 5 (16.7%) 3 (10%) 
2
III 6 (20%) 12 (40%) 12 (40%) P=0.27
IV 16 (53.3%) 13 (43.3%) 15 (50%)
Suffering pain
< 25min 17 (60.7%) 15 (51.7%) 15 (50%) 
2
26–50min 6 (21.4%) 10 (33.3%) 10 (33.3%) P=0.7
> 50min 7 (17.9%) 5 (17.2%) 5 (17.9%)
Figure 1. Means of difference between before and after intervention of
VAS pain score in three study groups for 5 days. Tukey HSD test:
Exp. & Pla. 1day (P<0.001), 2 days (P<0.0001), 3 days (P<0.04),
4 days (P<0.0001), 5 days (P<0.006); Exp. & Con. 1day (P<0.001),
2 days (P<0.0001), 3 days (P<0.001), 4 days (P<0.0001), 5 days
(P<0.001); Pla. & Con. 1day (P<0.14), 2 days (P<0.001), 3 days
(P<0.005), 4 days (P<0.008), 5 days (P<0.001).
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ANOVA (the means of difference between the RFS
fatigue scores before and after the intervention) showed
that there were significant differences between the three
groups within the 5 days of intervention (F=3.18, df
=8, P=0.002, n=90) (Figure 2).
The Tukey HSD test was conducted to locate the
differences. The Tukey test of the means of difference the
RFS fatigue scores between before and after intervention
showed that there was a significant difference between
the experimental and placebo groups in the first
(P<0.001), second (P<0.0001), third (P<0.03),
fourth (P<0.0001) and fifth days (P<0.0001) and
also between the experimental and control groups in the
first (P<0.001), second (P<0.0001), third (P<0.001),
fourth (P<0.001) and fifth days (P<0.001). There was
no significant difference between the placebo and control
groups in the first (P<0.18), fourth (P<0.43) and fifth
days (P<0.68), while there was a significant difference
between the placebo and control groups in the second
(P<0.05) and third days (P<0.001). Figure 2 shows
these values for 5 days.
Discussion
Complementary and alternative medicine (CAM) use
among people is generally high. Goldstein et al. (20)
found that those reporting a diagnosis of cancer and
those who report other chronic health problems indicate
a similar level of visits to CAM providers (20).
CAM therapies have been shown to decrease anxiety
and depression, to minimize pain and to boost immune
functioning. A systematic review of the evidence for the
efficacy of CAM in treating pain, dyspnea and nausea
and vomiting for patients near the end of life was
conducted. The efficacy of various CAM modalities was
evaluated in 21 studies of symptomatic adult patients.
The review found that acupuncture, transcutaneous
electrical nerve stimulation, supportive group therapy,
self-hypnosis and massage therapy may provide some
pain relief for patients with cancer and/or patients who
are dying (1).
The present trial aimed at testing the efficacy of TT
(as a CAM) in the cancer patients suffering from chronic
pain and fatigue. The results demonstrated that TT is
significantly more effective on the pain and fatigue of the
experimental group than on the placebo and control
groups. RCT studies for TT are frequently quoted in
support of this result. Ekes Peck (21) showed that the TT
decreased the pain in elders suffering from degenerative
arthritis (in this study, the comparative group was
undergoing progressive muscle relaxation and the TT
periods were six times) (21). The findings by Abbot et al.
(22) showed that spiritual healing, as a therapy for
chronic pain, significantly decreased pain intensity during
the sessions of therapies (22). Also, Denison (23) found
that TT decreased the intensity of pain in the patients
with Fibro-Myalgia Syndrome during the six sessions of
TT. Wez et al. (24) found that the healing by gentle touch
decreased pain in the clients with cancer within the
six sessions of treatment.
Post-White et al. (25), by a study on ‘Therapeutic
Massage and Healing Touch and Symptoms in Cancer’,
demonstrated that massage touch lowered anxiety and
healing touch lowered fatigue, and that both lowered
total mood disturbance. Pain ratings were lower after
massage touch and healing touch, when using less
non-steroidal anti-inflammatory drugs for 4 weeks (25).
The significant results are encouraging, since three
different individuals in three different facilities adminis-
tered the TT in the experimental group. These results
suggest that treatment is not dependent on the individual
attributes of the intervention.
The significant difference between the control and
placebo groups is of interest. A distinct positive linear
trend of decreasing pain and fatigue scores was noted
when the experimental group was compared to the
control group. Therefore, these differences indicated
the independent effect of TT on the pain and fatigue of
the cancer patients. The trend of decreasing pain and
fatigue in the placebo group when compared to the
control group indicated a placebo effect in TT.
Practitioner’s presence with distraction may have a
positive effect on the pain and fatigue of the patients.
Controversy exists on whether the TT intervention itself
produces the desired response or if the patient responds
to the presence of a caring professional. Presence
procedure is an important nursing intervention, helpful
in reducing anxiety. Several studies have used presence
procedure to control the intent of the practitioner as a
placebo effect (26, 27).
Figure 2. Means of difference between before and after intervention
of RFS fatigue score in three groups for 5 days. Tukey HSD test: Exp.
& Pla. 1day (P<0.001), 2 days (P<0.0001), 3 days (P<0.03), 4 days
(P<0.0001), 5 days (P<0.0001); Exp. & Con. 1day (P<0.001),
2 days (P<0.0001), 3 days (P<0.001), 4 days (P<0.001), 5 days
(P<0.001) Pla. & Con. 1day (P<0.18), 2 days (P<0.05), 3 days
(P<0.001), 4 days (P<0.43), 5 days (P<0.68).
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modalities, as well as, from scientific medicine, by its
emphasis on the healer’s intention. Whereas, the testing
of most therapies requires controlling for the placebo
effect (often influenced by the recipient’s belief about
efficacy), TT theorists suggest that the placebo effect is
irrelevant (28). The placebo TT may be interpreted as
compassionate touch, one–one social interaction or
nursing presence, all of which are known to have positive
effects (29). If the placebo intervention is interpreted as
any of these three categories of intervention, it may
explain a decrease in pain and fatigue of cancer patients
in the placebo group.
Limitations of the Study
Conducting a study in three group trials presents several
challenges, for there are numerous factors over which
the researcher has no control. All of the facilities used in
the present study were considerable for the practitioner,
although an effort was made to maintain consistent
facilities and environmental conditions, but some
conditions such as room temperature and noise were
uncontrollable. In addition, the study may be limited
by the participation of the principal investigator in
the intervention in one of the facilities. However,
a larger sample in a future studies could verify this
positive trend.
Implications for Research
The positive findings of this study support a growing
body of evidence that non-invasive, non-pharmacological
interventions such as TT are effective for decreasing
pain and fatigue of the cancer patients undergoing
chemotherapy with none of the untoward side effects of
psychotropic medications. One future thrust for
researches examining the effect of TT on pain and
fatigue of the cancer patients undergoing chemotherapy is
to examine physiological correlates to shed some light on
the mechanism of action of TT. This information can
provide valuable knowledge regarding the conditions
under which TT is most effective. Some questions
include: Is there a time of day that determines the
degree of effect? Is there a ‘loading dose’ requirement?
What is the optimal length of treatment for determining
dose-response? Future studies could test varying length
of intervention for optimal effect.
Additional questions are: What is the best specific
protocol for administering TT for the cancer patients
undergoing chemotherapy who have pain and fatigue?
Can therapeutic touch also be used to decrease depres-
sion, anxiety and stress in these patients?
Implications for Practice
Nursing is intimately involved with human care. TT is
one modality to convey caring. A paucity of information
related to the specific interventions for pain and fatigue
in the cancer patients undergoing chemotherapy exists,
suggesting that TT can be used to decrease pain and
fatigue of such patients and could be included in a total
philosophy of care for the people with cancer that focuses
on compassionate care.
Nurses are responsible for providing and managing the
care of cancer patients undergoing chemotherapy in
many settings: long-term care, adult day care, assisted
living and at home. At a time when cost containment is
a consideration in health care, TT is a modality that is
non-invasive, readily learned, and can provide a
non-pharmacological intervention for the selected pain
and fatigue of the these patients. TT can be applied in
many different settings such as home or day care, and
requires no specialized equipment. This non-pharmaco-
logical intervention warrants further nursing researches
especially in vulnerable populations (such as neonates
and the frail elderly), for whom invasive therapies are
problematic.
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